Neuraxis, INC
NRXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001933567
No open-market purchases or sales by Neuraxis, INC insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $19.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Neuraxis, INC as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +4 vs. Q1 2025
- Shares held
- 844.5K
- −75.1K (−8.2%) vs. Q1 2025
- Total value
- $2.04M
- +$67.1K (+3.4%) vs. Q1 2025
- New holders
- 6
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $19.2M |
| Q1 2026 | 26 | $14.7M |
| Q4 2025 | 18 | $6.88M |
| Q3 2025 | 18 | $2.49M |
| Q2 2025 | 17 | $2.04M |
| Q1 2025 | 13 | $1.98M |
| Q4 2024 | 12 | $939.3K |
| Q3 2024 | 9 | $789.5K |
| Q2 2024 | 10 | $308.3K |
| Q1 2024 | 8 | $232.6K |
| Q4 2023 | 7 | $201.4K |
| Q3 2023 | 6 | $207.2K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Neuraxis, INC; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 9 | $22 | 0.00% | +2+28.6% | Added |
| Bank of America Corp | 31 | $75 | 0.00% | +2+6.9% | Added |
| UBS Group AG | 575 | $1.39K | 0.00% | −1,796−75.7% | Reduced |
| Ulland Investment Advisors, LLC | 1,000 | $2.00K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 2,145 | $5.19K | 0.00% | +288+15.5% | Added |
| Morgan Stanley | 5,802 | $14.0K | 0.00% | +5,802 | New |
| LPL Financial LLC | 10,000 | $24.2K | 0.00% | +10,000 | New |
| Wealthcare Advisory Partners LLC | 15,188 | $36.8K | 0.00% | +15,188 | New |
| Royal Bank of Canada | 15,101 | $37.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 24,278 | $58.8K | 0.00% | −692−2.8% | Reduced |
| Citadel Advisors LLC | 25,524 | $61.8K | 0.00% | −1,297−4.8% | Reduced |
| Stifel Financial Corp | 25,710 | $62.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 27,981 | $67.7K | 0.00% | 00.0% | Unchanged |
| Manatuck Hill Partners, LLC | 50,416 | $122.0K | 0.05% | +50,416 | New |
| Parsons Capital Management Inc | 116,726 | $282.5K | 0.02% | 00.0% | Unchanged |
| Apis Capital Advisors, LLC | 124,024 | $300.1K | 0.11% | +124,024 | New |
| AIGH Capital Management LLC | 400,000 | $968.0K | 0.45% | +380,131+1,913.2% | Added |
| Creative Planning | 0 | $0 | 0.00% | −551,668−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −106,476−100.0% | Sold out |